Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunological Response Following Intradermal COVID-19 Vaccination as 3rd Dose Booster
TCTR20211102006Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 2 trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start Nov 2021; status: not yet recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211102006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211102006.